Recurrent Disease Completed Phase 1 / 2 Trials for Denosumab (DB06643)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03415477Denosumab: A Potential Treatment Option for Aneurysmal Bone CystsTreatment